Title: [Treatment of prostatic hypertrophy with synthetic progestational hormones].
Abstract:Prostate hypertrophy is common to about 75% of men over 60 years of age; surgical treatment is not always possible due to the clinical conditions of patients, or to their advanced age. 40 patients age...Prostate hypertrophy is common to about 75% of men over 60 years of age; surgical treatment is not always possible due to the clinical conditions of patients, or to their advanced age. 40 patients aged 50-88 affected with prostate hypertrophy in various degrees of severity, were treated with MAP (6-alpha-methyl-17-al pha-acetoxyprogesterone) by intramuscular administration of 200 mg MAP in 4 daily doses for 10 days, followed by 100 mg in 2 daily doses for another 10 days, and again 50 mg in 1 daily dose for the next 10 days. Patients were followed closely: urographic and cystographic examinations were done at beginning and at end of treatment. In most cases all clinical symptomatology was notably improved, with a great reduction in the number of urination problems; in some cases there was also a reduction in the volume of prostate hypertrophy; laboratory tests showed a marked improvement in all renal functions.Read More
Publication Year: 1971
Publication Date: 1971-09-01
Language: en
Type: article
Indexed In: ['pubmed']
Access and Citation
Cited By Count: 2
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot